Search hospitals > Ontario > KINGSTON
Kingston Health Sciences Centre
Claim this profileKINGSTON, Ontario K7L 2V7
Global Leader in Cancer
Global Leader in Adult T-Cell Leukemia/Lymphoma
Conducts research for Lung Cancer
Conducts research for Relapse
Conducts research for Lymphoid Hematopoietic Disease
341 reported clinical trials
38 medical researchers
Summary
Kingston Health Sciences Centre is a medical facility located in KINGSTON, Ontario. This center is recognized for care of Cancer, Adult T-Cell Leukemia/Lymphoma, Lung Cancer, Relapse, Lymphoid Hematopoietic Disease and other specialties. Kingston Health Sciences Centre is involved with conducting 341 clinical trials across 618 conditions. There are 38 research doctors associated with this hospital, such as Laura Wheaton, John Muscedere, MD, Elisa Brietzke, MD, PhD, and Stephanie Sibley, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Adult T-Cell Leukemia/Lymphoma
Global LeaderStage II
CD5 positive
Stage IV
Top PIs
Laura WheatonKingston Health Sciences Centre5 years of reported clinical research
Studies Cancer
Studies Adult T-Cell Leukemia/Lymphoma
16 reported clinical trials
55 drugs studied
John Muscedere, MDKingston Health Sciences Centre6 years of reported clinical research
Studies Gastrointestinal Bleeding
Studies Bleeding
4 reported clinical trials
6 drugs studied
Elisa Brietzke, MD, PhDKingston Health Sciences Centre1 year of reported clinical research
Studies Anxiety Disorder
Studies Anxiety
4 reported clinical trials
3 drugs studied
Stephanie Sibley, MDKingston Health Sciences Center2 years of reported clinical research
Studies Coronavirus
Studies Respiratory Failure
4 reported clinical trials
5 drugs studied
Clinical Trials running at Kingston Health Sciences Centre
Breast Cancer
Stroke
Testicular cancer
Multiple Myeloma
Asthma
Ovarian Cancer
Atrial Fibrillation
Cancer
Testicular Carcinoma
Ovarian Carcinoma
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Kingston Health Sciences Centre?
Where is Kingston Health Sciences Centre located?
Who should I call to ask about financial aid or insurance network?
What insurance does Kingston Health Sciences Centre accept?
What awards or recognition has Kingston Health Sciences Centre received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.